Cargando…

4-Aminopyridine improves real-life gait performance in SCA27B on a single-subject level: a prospective n-of-1 treatment experience

Detalles Bibliográficos
Autores principales:	Seemann, Jens, Traschütz, Andreas, Ilg, Winfried, Synofzik, Matthis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Letter to the Editors
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576659/ https://www.ncbi.nlm.nih.gov/pubmed/37439944 http://dx.doi.org/10.1007/s00415-023-11868-y

Ejemplares similares

Motor Training in Degenerative Spinocerebellar Disease: Ataxia-Specific Improvements by Intensive Physiotherapy and Exergames
por: Synofzik, Matthis, et al.
Publicado: (2014)

Real‐time use of audio‐biofeedback can improve postural sway in patients with degenerative ataxia
por: Fleszar, Zofia, et al.
Publicado: (2018)

Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects
por: Roeben, Benjamin, et al.
Publicado: (2023)

A de novo STUB1 variant associated with an early adult-onset multisystemic ataxia phenotype
por: Mengel, David, et al.
Publicado: (2021)

A longitudinal quantitative analysis of gait in patients with SCA-12
por: Siddique, Ummatul, et al.
Publicado: (2021)

Blood neurofilament light chain levels are associated with disease progression in a transgenic SCA3 mouse model
por: Mengel, David, et al.
Publicado: (2023)

The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patients
por: Thieme, Andreas, et al.
Publicado: (2022)

Neuroprotective Properties of 4-Aminopyridine
por: Dietrich, Michael, et al.
Publicado: (2021)

Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes
por: Aydin, Gülsah, et al.
Publicado: (2018)

Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3
por: Maas, Roderick P.P.W.M., et al.
Publicado: (2022)

Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study
por: Choubtum, Lulin, et al.
Publicado: (2015)

Validation of enhanced kinect sensor based motion capturing for gait assessment
por: Müller, Björn, et al.
Publicado: (2017)

Aminopyridine block of transient potassium current
Publicado: (1982)

2-Aminopyridin-3-ol
por: Betz, Richard, et al.
Publicado: (2011)

Bis(2-aminopyridine-κN (1))silver(I) nitrate
por: Fun, Hoong-Kun, et al.
Publicado: (2008)

The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factors
por: Hengel, Holger, et al.
Publicado: (2022)

Association between vestibulo-ocular reflex suppression, balance, gait, and fall risk in ageing and neurodegenerative disease: protocol of a one-year prospective follow-up study
por: Srulijes, Karin, et al.
Publicado: (2015)

2-Aminopyridin-1-ium triiodide
por: Reiss, Guido J., et al.
Publicado: (2013)

PolyQ-expanded ataxin-3 protein levels in peripheral blood mononuclear cells correlate with clinical parameters in SCA3: a pilot study
por: Gonsior, Kathrin, et al.
Publicado: (2020)

Identification of metabolites of dalfampridine (4-aminopyridine) in human subjects and reaction phenotyping of relevant cytochrome P450 pathways
por: Caggiano, Anthony, et al.
Publicado: (2013)

Tuscany SCA in action
por: Laws, Simon
Publicado: (2011)

Efficient Electrochemical N-Alkylation of N-Boc-Protected 4-Aminopyridines: Towards New Biologically Active Compounds
por: Feroci, Marta, et al.
Publicado: (2014)

Affective coding: the emotional dimension of agency
por: Gentsch, Antje, et al.
Publicado: (2014)

Tetrakis(4-aminopyridine-κN (1))dichloridocopper(II) monohydrate
por: Fun, Hoong-Kun, et al.
Publicado: (2008)

Identification of metabolites of dalfampridine (4-aminopyridine) in dog and rat
por: Caggiano, Anthony, et al.
Publicado: (2013)

Bis(2-aminopyridine)dibenzoatocobalt(II). Erratum
por: Ju, Wen-Zheng, et al.
Publicado: (2016)

Synthesis and Fluorescent Properties of Aminopyridines and the Application in “Click and Probing”
por: Li, Zongyang, et al.
Publicado: (2022)

Bis(2-aminopyridine-κN (1))bis(benzoato-κO)cobalt(II)
por: Zhong, Di-Chang, et al.
Publicado: (2007)

Dysfunctional neuro-muscular mechanisms explain gradual gait changes in prodromal spastic paraplegia
por: Lassmann, Christian, et al.
Publicado: (2023)

Dynamics of aminopyridine block of potassium channels in squid axon membrane
Publicado: (1976)

Effects of 4-aminopyridine on potassium currents in a molluscan neuron
Publicado: (1981)

2-Aminopyridinium (2-aminopyridine)trichloridonickelate(II)
por: Fun, Hoong-Kun, et al.
Publicado: (2008)

4-Aminopyridinium azide 4-aminopyridine solvate
por: Qian, Hui-Fen, et al.
Publicado: (2010)

4-Aminopyridine Decreases Progesterone Production by Porcine Granulosa Cells
por: Li, Yan, et al.
Publicado: (2003)

1-Allyl-2-aminopyridin-1-ium bromide
por: Seethalakshmi, T., et al.
Publicado: (2013)

Optical triggered seizures using a caged 4-Aminopyridine
por: Zhao, Mingrui, et al.
Publicado: (2015)

Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose
por: Ballesta Méndez, Maria, et al.
Publicado: (2014)

Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
por: Kalla, Roger, et al.
Publicado: (2019)

Discovery of aminopyridine-containing spiro derivatives as EGFR mutations inhibitors
por: Ye, Lianbao, et al.
Publicado: (2019)

Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175
por: Oh, SeCheol, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htkhm7ev89995vlgm2bocctp0o